Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mohler

Showing results (81-90 of 368) with videos related to

Pageof 37
Sort By:
Southern Medical Journal|September 1, 1978
Small airway disease: comparison of tests in young smokers versus nonsmokersG N Harrison, G R Moor, J L Mohler, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Fourier analysis of cell motility: correlation of motility with metastatic potentialA W Partin, J S Schoeniger, J L Mohler, et al.
Urology|March 27, 2007
Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer InstituteKhurshid A Guru, Hyung L Kim, Pamela M Piacente, et al.
Cancer Research|August 1, 1988
Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma modelJ L Mohler, A W Partin, J T Isaacs, et al.
Carcinogenesis|September 2, 1999
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)R M Lunn, D A Bell, J L Mohler, et al.
Urology|March 1, 1994
Effects of alpha-adrenergic agonist on neobladder water and electrolyte transportJ G Van Savage, S A McSherry, H Lepor, et al.
Current Opinion in Supportive and Palliative Care|November 6, 2013
Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancerJames T Dalton, Ryan P Taylor, Michael L Mohler, et al.
The Journal of Urology|August 13, 2003
Racial differences in androgen receptor protein expression in men with clinically localized prostate cancerKris E Gaston, Desok Kim, Swaroop Singh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
A method for using life tables to estimate lifetime risk for prostate cancer deathHyung L Kim, Marvin R Puymon, Maochun Qin, et al.
Expert Opinion on Therapeutic Patents|February 11, 2010
Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapyMichael L Mohler, Yali He, Zhongzhi Wu, et al.
Pageof 37

Showing results (81-90 of 368) with videos related to

Sort By:
Pageof 37
Southern Medical Journal|September 1, 1978
Small airway disease: comparison of tests in young smokers versus nonsmokersG N Harrison, G R Moor, J L Mohler, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Fourier analysis of cell motility: correlation of motility with metastatic potentialA W Partin, J S Schoeniger, J L Mohler, et al.
Urology|March 27, 2007
Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer InstituteKhurshid A Guru, Hyung L Kim, Pamela M Piacente, et al.
Cancer Research|August 1, 1988
Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma modelJ L Mohler, A W Partin, J T Isaacs, et al.
Carcinogenesis|September 2, 1999
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)R M Lunn, D A Bell, J L Mohler, et al.
Urology|March 1, 1994
Effects of alpha-adrenergic agonist on neobladder water and electrolyte transportJ G Van Savage, S A McSherry, H Lepor, et al.
Current Opinion in Supportive and Palliative Care|November 6, 2013
Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancerJames T Dalton, Ryan P Taylor, Michael L Mohler, et al.
The Journal of Urology|August 13, 2003
Racial differences in androgen receptor protein expression in men with clinically localized prostate cancerKris E Gaston, Desok Kim, Swaroop Singh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
A method for using life tables to estimate lifetime risk for prostate cancer deathHyung L Kim, Marvin R Puymon, Maochun Qin, et al.
Expert Opinion on Therapeutic Patents|February 11, 2010
Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapyMichael L Mohler, Yali He, Zhongzhi Wu, et al.
Pageof 37